dokumendiregister.ee
Sissetulev kiriAvalik

Euroopa farmakopöa asjus

Ravimiamet · 28. veebruar 2025
Viit
REP-1/1045-1
Registreeritud
28. veebruar 2025
Dokumendi liik
Sissetulev kiri
Adressaat
European Directorate for the Quality of Medicines & HealthCare
Saabumis/saatmisviis
e-post
Funktsioon
REP Euroopa Farmakopöaga seotud asjaajamine
Sari
REP-1 Euroopa Farmakopöa alane kirjavahetus
Toimik
REP-1/2025
Vastutaja
Signe Leito (RA, Peadirektori asetäitja valdkond, Labor)

Failid

Sisu (failidest)

Signe Leito Saatja: [email protected] Saatmisaeg: kolmapäev, 26. veebruar 2025 09:52 Adressaat: Signe Leito Teema: Proposed suppression of the monograph on Ouabain 0048 from the Ph. Eur.: EDQM-2025-00946-mail Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Please make sure to include in any reply our mail reference: EDQM-2025-00946-mail **************************************************************************** European Pharmacopoeia Commission Secretariat RZ/PH/ 2025-00943L Aba/mk Strasbourg, 25 February 2025 LETTER FOR THE ATTENTION OF THE NPAs Copy: Presidium Dear Colleagues, Please find below the link to a survey being carried out concerning the proposed suppression of the monograph on Ouabain (0048) from the work programme of group of experts 11. Please copy and paste this link into your Internet browser: https://survey.edqm.eu/index.php?r=survey/index&sid=685725&lang=en Deadline for replies: 13 March 2025 1 Kind regards, On behalf of Aurélie BARTH Mireille Kopf Secretarial Assistant European Pharmacopoeia Department EDQM - Council of Europe Tel.: +33 (0)3 88 41 28 53 / Fax: +33 (0)3 88 41 27 71 https://www.edqm.eu / https://store.edqm.eu Stay connected with the EDQM **************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2025-00946-mail 2
Allikas: Ravimiamet dokumendiregister →